Cargando…
KRAS, NRAS, BRAF mutation comparison of endoscopic and surgically removed primary CRC paired samples: is endoscopy biopsy material adequate for molecular evaluation?
BACKGROUND: An everyday clinical practice dilemma in the 20–30% of metastatic colorectal cancer (CRC) patients that have not been operated on their primary tumour, is, under which specific histopathology and molecular circumstances, an endoscopic biopsy could be considered adequate to provide a repr...
Autores principales: | Saridaki, Z, Saegart, X, De Vriendt, V, Hatzidaki, D, Palmans, S, De Smedt, L, De Hertogh, G, Tejpar, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578093/ https://www.ncbi.nlm.nih.gov/pubmed/26325103 http://dx.doi.org/10.1038/bjc.2015.307 |
Ejemplares similares
-
KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma
por: Pasca, Sergiu, et al.
Publicado: (2019) -
Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching
por: De Smedt, Linde, et al.
Publicado: (2017) -
Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer
por: Gökmen, İvo, et al.
Publicado: (2023) -
The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
por: Eklöf, V, et al.
Publicado: (2013) -
Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis
por: De Smedt, L, et al.
Publicado: (2015)